Emily Kramer-Golinkoff can't get enough oxygen with each breath. Advanced cystic fibrosis makes even simple things like ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

A team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

Here’s what Catholics should know about the dire wolves and what the Church might have to say about “resurrecting” extinct species of animals.

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Prime Medicine, Inc.’s PRME share price has dipped by 5.43%, which has investors questioning if this is right time to buy.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

Pioneering research led by the University of Bristol has repurposed a gene-editing tool to help shed light on the true ...